|
|
|
Infinity's Cancer Drug Looks Promising
May 31, 2008
Julian Adams, Infinity Pharmaceuticals chief scientific officer, speaks to MarketWatch's Val Kennedy about promising data for its gastrointestinal cancer drug, IPI-504. The company plans to move directly into Phase-III testing. (May 31)
|
|
|